Terms: = Breast cancer AND GATA3, HDR, 2625, ENSG00000107485, MGC5445, MGC5199, MGC2346
894 results:
1. Genomic Landscape of Circulating Tumor DNA in Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-2-Negative Metastatic breast cancer Treated With Abemaciclib: Data From the SCRUM-Japan cancer Genome Screening Project.
Hattori M; Serelli-Lee V; Naito Y; Yamanaka T; Yasojima H; Nakamura R; Fujisawa T; Imai M; Nakamura Y; Bando H; Kawaguchi T; Yoshino T; Iwata H
JCO Precis Oncol; 2024 Apr; 8():e2300647. PubMed ID: 38635933
[TBL] [Abstract] [Full Text] [Related]
2. Subtyping of triple-negative breast cancers: its prognostication and implications in diagnosis of breast origin.
Hu H; Tong K; Tsang JY; Ko CW; Tam F; Loong TC; Tse GM
ESMO Open; 2024 Apr; 9(4):102993. PubMed ID: 38613910
[TBL] [Abstract] [Full Text] [Related]
3. Deep learning for high-resolution dose prediction in high dose rate brachytherapy for breast cancer treatment.
Quetin S; Bahoric B; Maleki F; Enger SA
Phys Med Biol; 2024 Apr; 69(10):. PubMed ID: 38604185
[No Abstract] [Full Text] [Related]
4. An integrated approach to understand the regulatory role of miR-27 family in breast cancer metastasis.
Chakraborty S; Paul U; Banerjee S; Saha D; Banerjee S
Biosystems; 2024 Apr; 238():105200. PubMed ID: 38565418
[TBL] [Abstract] [Full Text] [Related]
5. Gastric metastasis from breast cancer: five cases and a single-institutional review.
Cheng M; Jia Z; Zhang G; Wang Y; Li S; Yang S; Li C; Geng C
J Int Med Res; 2024 Mar; 52(3):3000605241233988. PubMed ID: 38483129
[TBL] [Abstract] [Full Text] [Related]
6. Circulating tumor DNA for predicting recurrence in patients with operable breast cancer: a systematic review and meta-analysis.
Nader-Marta G; Monteforte M; Agostinetto E; Cinquini M; Martins-Branco D; Langouo M; Llombart-Cusac A; Cortés J; Ignatiadis M; Torri V; Apolone G; Cappelletti V; Pruneri G; de Azambuja E; Di Cosimo S
ESMO Open; 2024 Mar; 9(3):102390. PubMed ID: 38460249
[TBL] [Abstract] [Full Text] [Related]
7. Functional analysis and clinical classification of 462 germline BRCA2 missense variants affecting the DNA binding domain.
Hu C; Huang H; Na J; Lumby C; Abozaid M; Holdren MA; Rao TJ; Karam R; Pesaran T; Weyandt JD; Csuy CM; Seelaus CA; Young CC; Fulk K; Heidari Z; Morais Lyra PC; Couch RE; Persons B; Polley EC; Gnanaolivu RD; Boddicker NJ; Monteiro ANA; Yadav S; Domchek SM; Richardson ME; Couch FJ
Am J Hum Genet; 2024 Mar; 111(3):584-593. PubMed ID: 38417439
[TBL] [Abstract] [Full Text] [Related]
8. Clinical sequencing defines the somatic and germline mutation landscapes of Chinese HER2-Low breast cancer.
Han BY; Chen C; Luo H; Lin CJ; Han XC; Nasir J; Shi JX; Huang W; Shao ZM; Ling H; Hu X
Cancer Lett; 2024 Apr; 588():216763. PubMed ID: 38403109
[TBL] [Abstract] [Full Text] [Related]
9. Whole-Genome Sequencing Analysis of Male breast cancer Unveils Novel Structural Events and Potential Therapeutic Targets.
Al Assaad M; Michaud O; Semaan A; Sigouros M; Tranquille M; Phan A; Levine MF; Gundem G; Medina-Martínez JS; Papaemmanuil E; Manohar J; Wilkes D; Sboner A; Hoda SAF; Elemento O; Mosquera JM
Mod Pathol; 2024 Apr; 37(4):100452. PubMed ID: 38369186
[TBL] [Abstract] [Full Text] [Related]
10. Invasive micropapillary carcinoma of the breast and bilateral ovarian mature cystic teratoma with benign Brenner tumor in a postmenopausal woman - An uncommon occurrence.
Ayyanar P; Mitra S; Imaduddin M; Muduly DK
Indian J Pathol Microbiol; 2024; 67(1):189-191. PubMed ID: 38358219
[TBL] [Abstract] [Full Text] [Related]
11. A Metabolic-Epigenetic Mechanism Directs Cell Fate and Therapeutic Sensitivity in breast cancer.
Bernard MJ; Goldstein AS
Cancer Res; 2024 May; 84(9):1382-1383. PubMed ID: 38330100
[TBL] [Abstract] [Full Text] [Related]
12. The androgen receptor interacts with gata3 to transcriptionally regulate a luminal epithelial cell phenotype in breast cancer.
Hosseinzadeh L; Kikhtyak Z; Laven-Law G; Pederson SM; Puiu CG; D'Santos CS; Lim E; Carroll JS; Tilley WD; Dwyer AR; Hickey TE
Genome Biol; 2024 Feb; 25(1):44. PubMed ID: 38317241
[TBL] [Abstract] [Full Text] [Related]
13. Genomic transcription factor binding site selection is edited by the chromatin remodeling factor CHD4.
Saotome M; Poduval DB; Grimm SA; Nagornyuk A; Gunarathna S; Shimbo T; Wade PA; Takaku M
Nucleic Acids Res; 2024 Apr; 52(7):3607-3622. PubMed ID: 38281186
[TBL] [Abstract] [Full Text] [Related]
14. A Comparative Evaluation of TRPS1 and gata3 in adenoid cystic, secretory, and acinic cell carcinomas of the breast and salivary gland.
Salem A; Wu Y; Albarracin CT; Middleton LP; Kalhor N; Peng Y; Huang X; Aung PP; Chen H; Sahin AA; Ding Q
Hum Pathol; 2024 Mar; 145():42-47. PubMed ID: 38262580
[TBL] [Abstract] [Full Text] [Related]
15. Intraoperative Radiation Therapy Delivered by Brachytherapy in breast cancer: An Interim Analysis of a Phase 2 Trial.
Wickberg Å; Prag C; Valachis A; Karlsson L; Johansson B
Clin Breast Cancer; 2024 Apr; 24(3):243-252. PubMed ID: 38185607
[TBL] [Abstract] [Full Text] [Related]
16. TRPS1 is a promising marker for all subtypes of breast cancer.
Lui JW; Tsang JY; Li J; Ko CW; Tam F; Loong TC; Tse GM
Histopathology; 2024 Apr; 84(5):822-836. PubMed ID: 38173281
[TBL] [Abstract] [Full Text] [Related]
17. Deregulation of miR-1245b-5p and miR-92a-3p and their potential target gene, gata3, in epithelial-mesenchymal transition pathway in breast cancer.
Yadollahi Farsani M; Amini Farsani Z; Teimuri S; Kolahdouzan M; Eshraghi Samani R; Teimori H
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1955. PubMed ID: 38173189
[TBL] [Abstract] [Full Text] [Related]
18. Clinicopathologic and genetic analysis of invasive breast carcinomas in women with germline CHEK2 variants.
Schwartz CJ; Khorsandi N; Blanco A; Mukhtar RA; Chen YY; Krings G
Breast Cancer Res Treat; 2024 Feb; 204(1):171-179. PubMed ID: 38091153
[TBL] [Abstract] [Full Text] [Related]
19. [TRPS1 expression in salivary gland-type breast carcinoma and its clinical application].
Xu C; Han X; Xu JC; Wang C
Zhonghua Bing Li Xue Za Zhi; 2023 Dec; 52(12):1261-1265. PubMed ID: 38058044
[No Abstract] [Full Text] [Related]
20. TRPS1 expression in primary and metastatic prostatic adenocarcinoma, muscle invasive bladder urothelial carcinoma, and breast carcinoma: Is TRPS1 truly specific and sensitive for a breast primary?
Bachert SE; Di J; Zhang S; Short HE; Piecoro DW; McDonald RJ; Myint ZW; Hensley PJ; Allison DB
Hum Pathol; 2024 Jan; 143():42-49. PubMed ID: 38052269
[TBL] [Abstract] [Full Text] [Related]
[Next]